ENZYME PROFILE OF PERIPHERAL BLOOD LYMPHOCYTES IN PATIENTS WITH THE RENAL CELL CARCINOMA BEFORE AND AFTER SURGICAL TREATMENT

The aim of the study was to investigate activities of NAD- and NADP-dependent dehydrogenases in peripheral blood lymphocytes of the patients with renal cell carcinoma (RCC) at the terms before surgery and 14 and 30 days after surgical treatment. The patients at the age of 45-55 years with locally advanced RCC were examined before surgical treatment, 14 and 30 days after surgery. The control group consisted of healthy donors of the same age range. Activity of NAD- and NADP-dependent dehydrogenases was determined by bioluminescence method using bienzyme complex isolated from luminescent bacteria. The enzyme profile changes of peripheral blood lymphocytes in the patients with RCC in pre- and postoperative period have been revealed. The lymphocyte metabolism in patients with RCC at the pre-operative period was characterized by decreased activity of pentose phosphate cycle, and glutathione-dependent antioxidant system. The changes in activity of these processes may lead to decreased levels of macromolecular synthetic reactions in the lymphocytes and activation of peroxide reactions. We have registered a decreased activity of lactate dehydrogenase anaerobic reaction which characterizes inhibition of the terminal anaerobic glycolysis reactions. The levels of metabolic reactions in blood lymphocytes from the RCC patients in preoperative period determining the intensity of aerobic respiration corresponded to control values, along with an increased intensity of the NAD-dependent substrates outflow from the tricarboxylic acid cycle to the amino acid exchange reaction. In the postoperative period in patients with RCC in blood lymphocytes the activity of the terminal reactions of the anaerobic glycolysis hold on, the aerobic lactate dehydrogenase reaction moderately activated. During the entire postoperative period, an increased outflow of NAD-dependent substrates from the tricarboxylic acid cycle to the amino acid exchange reaction is registered in blood lymphocytes of RCC patients. Nevertheless, there is a significant increase in the intensity of the Krebs cycle terminal reactions, which determines an increase in aerobic respiration activity being energetically more beneficial to the cells. At the same time, «impoverishment» of the pentose phosphate cycle metabolites in the lymphocytes of the patients with RCC, due to similar redistribution of the substrate flows, leads to decreased plastic processes in cells. Even 30 days after surgical treatment, a decrease remains in glutathione-dependent antioxidant protection of the cells. Therefore, the patients with RCC need correction of metabolic processes in the immune cells during postoperative period. This fact should be taken into account by developing rehabilitation programs in this category of the patients.

1. Aleksandrova L.M., Gretsova O.P., Kalinina A.M., Petrova G.V., Starinskiy V.V., Kaprin A.D., Boytsov S.A. Role of prophylactic medical examination in the detection of kidney cancer in Russia. Onkologiya. Zhurnal im. P.A. Gertsena = Oncology. P.A. Herzen Journal, 2015, Vol. 4, no. 5, pp. 44-48. (In Russ.)

2. Vtorushin S.V., Tarakanova V.O., Zavyalova M.V. Molecular biological predictors for kidney cancer. Arkhiv patologii = Archive of Pathology, 2016, Vol. 78, no. 1, pp. 56-61. (In Russ.)

3. Zukov R.A., Dykhno Yu.A., Modestov A.A., Shkapova E.A. Renal cell cancer. Novosibirsk: Science, 2015. 244 p.

4. Kadagidze Z.G., Chertkova A.I., Slavina E.G., Zabotina E.N., Borunova A.A., Korotkova O.V. Phenotype of immunocompetent cells and its role in antitumour immune response. Vestnik RAMN = Annals of the Russian Academy of Medical Sciences, 2011, no. 12, pp. 21-25. (In Russ.)

5. Kolenchukova O.A., Savchenko A.A. Comparative characteristics of NAD(P) – dependent dehydrogenases in blood lymphocytes and lymphoid tissue in chronic adenoiditis. Meditsinskaya immunologiya = Medical Immunology (Russia), 2015, Vol. 17, no. 3, pp. 229-234. (In Russ.) doi: 10.15789/1563-0625-2015-3-229-234.

6. Kurtasova L.M., Manchuk V.T., Savchenko A.A. Fundamentals of the metabolic immunorehabilitation of children with atopic dermatitis. Krasnoyarsk: KrasGMA, 2002. 153 p.

7. Savchenko A.A. Evaluation of NAD(P)-dependent dehydrogenase activities in neutrophilic granulocytes by the bioluminescent method. Byulleten eksperimentalnoy biologii i meditsiny = Bulletin of Experimental Biology and Medicine, Vol. 159, no. 5, pp. 656-660. (In Russ.)

8. Savchenko A.A., Zdzitovetskiy D.E., Borisov A.G. The immune and metabolic disorders by the widespread purulent peritonitis. Novosibirsk: Science, 2013. 142 p.

9. Basappa N., Pouliot F. New research in kidney cancer, ASCO-GU 2017. Can. Urol. Assoc. J., 2017, Vol. 11, Suppl. l2, pp. S163-S165.

10. Boonyuen U., Chamchoy K., Swangsri T., Junkree T., Day N.P.J., White N.J., Imwong M. A trade off between catalytic activity and protein stability determines the clinical manifestations of glucose-6-phosphate dehydrogenase (G6PD) deficiency. Int. J. Biol. Macromol., 2017, Vol. 104, Pt A, pp. 145-156.

11. Bunik V., Artiukhov A., Aleshin V., Mkrtchyan G. Multiple forms of glutamate dehydrogenase in animals: Structural determinants and physiological implications. Biology (Basel), 2016, Vol. 5, no. 4, pii: E53.

12. Chang C.H., Curtis J.D., Maggi L.B. Jr., Faubert B., Villarino A.V., O’Sullivan D., Huang S.C., van der Windt G.J., Blagih J., Qiu J., Weber J.D., Pearce E.J., Jones R.G., Pearce E.L. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell, 2013, Vol. 153, no. 6, pp. 1239-1251.

13. Couto N., Wood J., Barber J. The role of glutathione reductase and related enzymes on cellular redox homoeostasis network. Free Radic. Biol. Med., 2016, Vol. 95, pp. 27-42.

14. Gerriets V.A., Kishton R.J., Nichols A.G., Macintyre A.N., Inoue M., Ilkayeva O., Winter P.S., Liu X., Priyadharshini B., Slawinska M.E., Haeberli L., Huck C., Turka L.A., Wood K.C., Hale L.P., Smith P.A., Schneider M.A., MacIver N.J., Locasale J.W., Newgard C.B., Shinohara M.L., Rathmell J.C. Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. J. Clin. Invest., 2015, Vol. 125, no. 1, pp. 194-207.

15. Leoni V., Nury T., Vejux A., Zarrouk A., Caccia C., Debbabi M., Fromont A., Sghaier R., Moreau T., Lizard G. Mitochondrial dysfunctions in 7-ketocholesterol-treated 158N oligodendrocytes without or with α-tocopherol: Impacts on the cellular profil of tricarboxylic cycle-associated organic acids, long chain saturated and unsaturated fatty acids, oxysterols, cholesterol and cholesterol precursors. J. Steroid Biochem. Mol. Biol., 2017, Vol. 169, pp. 96-110.

16. Li L., Fath M.A., Scarbrough P.M., Watson W.H., Spitz D.R. Combined inhibition of glycolysis, the pentose cycle, and thioredoxin metabolism selectively increases cytotoxicity and oxidative stress in human breast and prostate cancer. Redox Biol., 2015, Vol. 4, pp. 127-135.

17. Li M., Song M., Ren L.M., Xiu C.Y., Liu J.Y., Zhu Y.Z., Li Y.F. AlCl3 induces lymphocyte apoptosis in rats through the mitochondria-caspase dependent pathway. Environ. Toxicol., 2016, Vol. 31, no. 4, pp. 385-394.

18. Medvedeva S.E., Tyulkova N.A., Kuznetsov A.M., Rodicheva E.K. Bioluminescent bioassays based on luminous bacteria. Journal of Siberian Federal University. Biology, 2009, Vol. 2, no. 4, pp. 418-452.

19. Melis D., Carbone F., Minopoli G., La Rocca C., Perna F., De Rosa V., Galgani M., Andria G., Parenti G., Matarese G. Cutting edge: Increased autoimmunity risk in glycogen storage disease type 1b is associated with a reduced engagement of glycolysis in t cells and an impaired regulatory T cell function. J. Immunol., 2017, Vol. 198, no. 10, pp. 3803-3808.

20. Nassif E., Thibault C., Vano Y., Fournier L., Mauge L., Verkarre V., Timsit M.O., Mejean A., Tartour E., Oudard S. Sunitinib in kidney cancer: 10 years of experience and development. Expert Rev. Anticancer Ther., 2017, Vol. 17, no. 2129-2142.

21. Previte D.M., O’Connor E.C., Novak E.A., Martins C.P., Mollen K.P., Piganelli J.D. Reactive oxygen species are required for driving efficient and sustained aerobic glycolysis during CD4+ T cell activation. PLoS ONE, 2017, Vol. 12, no. 4, pp. e0175549. doi: 10.1371/journal.pone.0175549.

22. Sharabi A. Editorial: Molecules balancing immunological surveillance against cancer and autoimmune diseases. Front. Oncol., 2016, Vol. 6, p. 86.

23. Smirnova O.V., Manchouk V.T., Savchenko A.A. Immune status and enzymes activity in blood lymphocytes in adult patients at different stages of acute lymphoblastic leukemia. Indian Journal of Medical Research, 2011, Vol. 133, pp. 280-286.

24. Thakor P., Subramanian R.B., Thakkar S.S., Ray A., Thakkar V.R. Phytol induces ROS mediated apoptosis by induction of caspase 9 and 3 through activation of TRAIL, FAS and TNF receptors and inhibits tumor progression factor Glucose 6 phosphate dehydrogenase in lung carcinoma cell line (A549). Biomed. Pharmacother., 2017, Vol. 92, pp. 491-500.

25. Xu Y., Chaudhury A., Zhang M., Savoldo B., Metelitsa L.S., Rodgers J., Yustein J.T., Neilson J.R., Dotti G. Glycolysis determines dichotomous regulation of T cell subsets in hypoxia. J. Clin. Invest., 2016, Vol. 126, no. 7, pp. 2678-2688.

26. Zhu M., Fang J., Zhang J., Zhang Z., Xie J., Yu Y., Ruan J.J., Chen Z., Hou W., Yang G., Su W., Ruan B.H. Biomolecular interaction assays identified dual inhibitors of glutaminase and glutamate dehydrogenase that disrupt mitochondrial function and prevent growth of cancer cells. Anal. Chem., 2017, Vol. 89, no. 3, pp. 1689-1696.